Cytek Biosciences (CTKB) Change in Account Payables (2020 - 2026)
Cytek Biosciences (CTKB) posted Change in Account Payables of $390000.0 for Q1 2026, up 129.79% on a QoQ basis from -$1.3 million in Q4 2025, and down 4.88% year-over-year from $410000.0 in Q1 2025.
Cytek Biosciences (CTKB) Change in Account Payables (2020 - 2026) Analysis & Trends
Cytek Biosciences' Change in Account Payables history runs 7 years deep, the most recent figure standing at $390000.0 for Q1 2026.
- Quarterly Change in Account Payables fell 4.88% year-over-year to $390000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428000.0 (down 81.99% YoY) and the FY2025 annual result came in at $448000.0, down 82.65% from the prior year.
- Change in Account Payables was $390000.0 for Q1 2026 at Cytek Biosciences, up from -$1.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.8 million in Q1 2022 and bottomed at -$2.0 million in Q2 2023.
- A 5-year average of $205764.7 and a median of $390000.0 in 2026 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 2383.93% — and 2025, when it tumbled 607.36%.
- Cytek Biosciences' Change in Account Payables stood at -$908000.0 in 2022, then plunged by 97.58% to -$1.8 million in 2023, then surged by 114.38% to $258000.0 in 2024, then tumbled by 607.36% to -$1.3 million in 2025, then jumped by 129.79% to $390000.0 in 2026.
- Business Quant data shows CTKB's Change in Account Payables at $390000.0 in Q1 2026, -$1.3 million in Q4 2025, and $588000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | - |
| 10 | Cytek Biosciences | 565.01 Mn | 499.31 Mn | 21.25 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 390,000.00 |
| Mar 31, 2026 | 390,000.00 |
| Dec 31, 2025 | -1.31 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | 588,000.00 |
| Sep 30, 2025 | 588,000.00 |
| Jun 30, 2025 | 759,000.00 |
| Jun 30, 2025 | 759,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | -519,000.00 |
| Jun 30, 2024 | -519,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Dec 31, 2023 | -1.79 Mn |
| Dec 31, 2023 | -1.79 Mn |